Compare · SERM
Clomiphene vs Raloxifene
Both are serm compounds. Here's how they line up on the evidence — graded the same way.
| Clomiphene | Raloxifene | |
|---|---|---|
| Evidence | 10/10 | 10/10 |
| Class | SERM | SERM |
| Summary | Clomiphene is a selective estrogen receptor modulator (SERM), not a peptide, with strong human evidence that it raises testosterone in hypogonadal men while preserving fertility; male use is off-label, it is prescription-only, and it is banned in sport at all times. | Raloxifene is a selective estrogen receptor modulator (SERM) — an FDA-approved postmenopausal osteoporosis and breast-cancer-risk-reduction drug, not a peptide. Its defining serious risks are blood clots and fatal stroke; it is banned in sport at all times (WADA S4.2). |
| Full profile → | Full profile → |
Clomiphene
Clomiphene keeps getting lumped in with peptides and "research chemicals" in fitness circles, but it is neither. It is a selective estrogen receptor modulator (a drug that turns the body's estrogen signals up in some tissues and down in others) — a small-molecule oral drug in the same chemical…
Raloxifene
Raloxifene, sold as Evista, is a pill taken once a day. It belongs to a group of drugs called SERMs — selective estrogen receptor modulators (medicines that switch estrogen's effects on or off depending on which part of the body they reach). It's a legitimate, well-studied prescription drug. It…